The results revealed that IL-13 significantly enhanced C/EBP-α/COX-2 expression and PGE2 production in LPS-treated microglial cells. Paradoxically, IL-13 abolished C/EBP-β/PPAR-γ/HO-1
expression. IL-13 also enhanced ER stress-evoked calpain activation by promoting the association of C/EBP-β and PPAR-γ. SiRNA-C/EBP-α effectively reversed the combined LPS-activated caspase-12 activation and IL-13-induced apoptosis. In contrast, siRNA-C/EBP-β partially increased microglial PI3K inhibitor cell apoptosis. By NeuN immunochemistry and CD11b staining, there was improvement in the loss of CA3 neuronal cells after intrahippocampal injection of IL-13. This suggests that IL-13-enhanced PLA2 activity regulates COX-2/PGE2 expression through C/EBP-α activation. In parallel, ER stress-related calpain downregulates the PPAR-γ/HO-1 pathway via C/EBP-β and leads to aggravated
death of activated microglia via IL-13, thereby preventing cerebral inflammation and neuronal injury. Microglial cell Selleck Navitoclax activation is exquisitely sensitive to brain injury and diseases that contribute to neuronal cell death (e.g. repeated infection, traumatic brain damage, and stroke). Such activation likely plays a crucial role in inflammatory neuronal injury and chronic neurodegenerative diseases . Anti-inflammatory medications may be protective against brain damage. Emerging evidence indicates that endoplasmic reticulum
(ER) stress plays a pivotal role in the pathogenesis of neurodegeneration . The ER activates the unfolded protein response, a signaling pathway for adaptive response, which initially exerts a protective effect by upregulating specific ER stress-regulated genes and inhibiting general protein translation [3, 4]. However, severe or prolonged ER stress results in cell death via apoptotic signaling, ultimately leading to neurodegeneration. A previous study has shown that IL-13 downregulates peroxisome aminophylline proliferator-activated receptor gamma/heme oxygenase 1 (PPAR-γ/HO-1) via ER stress-stimulated calpain activation. Thus, IL-13 may reduce chronic brain inflammation . This finding is consistent with the findings of Yang et al.  showing that IL-13 enhances cyclooxygenase-2 (COX-2) expression in activated rat brain microglia, thereby reducing brain inflammation. Recently, Kawahara et al.  suggested that intracerebral microinjection of IL-4/IL-13 reduces β-amyloid accumulation on the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice. However, the mechanisms underlying how IL-13 regulates activated microglia and its relationship with the dampening of neuronal death have not been well elucidated. Studies on the relationship between glial activation and neurotoxicity have identified several molecular targets for transcription factor research.